| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 1376-1379, Copyright © 1993 by Endocrine Society
ARTICLES |
I Bussenot, C Azoulay-Barjonet and J Parinaud
Inserm CJF 89-08, CHR La Grave, Toulouse, France.
GnRH analogs are widely used in reproductive medicine to create a hypogonadotropic hypogonadism. However, numerous animal studies have demonstrated a direct regulation of the gonadal function by GnRH. To ascertain this direct ovarian effect in humans, the steroidogenesis of cultured human granulosa cells was studied with or without GnRH and five of its agonists. Buserelin (D-Ser(But)6, desGly10) GnRH ethylamide, leuprorelin (D-Leu6, desGly10) GnRH ethylamide, H4055 (desGly10) GnRH ethylamide, and H4065 (D-Trp6, desGly10) GnRH ethylamide significantly enhanced estradiol secretion. In addition, buserelin induced a significant cell surface decrease that seemed to be mediated by cytoskeleton modifications. The two other molecules, GnRH and triptorelin (D-Trp6) GnRH), had no effect on estrogen secretion at any of the studied concentrations. Thus, despite similar pituitary effects, these agonists did not exhibit the same ovarian action. This may be accounted for by the differences found between pituitary and ovarian receptors. These results suggest that some GnRH analogs can modulate human granulosa cell steroidogenesis at least in the preovulatory period.
This article has been cited by other articles:
![]() |
C. Metallinou, B. Asimakopoulos, A. Schroer, and N. Nikolettos Gonadotropin-Releasing Hormone in the Ovary Reproductive Sciences, December 1, 2007; 14(8): 737 - 749. [Abstract] [PDF] |
||||
![]() |
A. Sengupta, T. Baker, N. Chakrabarti, J. A. Whittaker, and R. Sridaran Localization of Immunoreactive Gonadotropin-releasing Hormone and Relative Expression of Its mRNA in the Oviduct During Pregnancy in Rats J. Histochem. Cytochem., May 1, 2007; 55(5): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kitajima, T. Endo, K. Nagasawa, K. Manase, H. Honnma, T. Baba, T. Hayashi, H. Chiba, N. Sawada, and T. Saito Hyperstimulation and a Gonadotropin-Releasing Hormone Agonist Modulate Ovarian Vascular Permeability by Altering Expression of the Tight Junction Protein Claudin-5 Endocrinology, February 1, 2006; 147(2): 694 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yeung, B.-S. An, C. K. Cheng, B. K.C. Chow, and P. C.K. Leung Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells Mol. Hum. Reprod., November 1, 2005; 11(11): 837 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. An, J.-H. Choi, K.-C. Choi, and P. C. K. Leung Differential Role of Progesterone Receptor Isoforms in the Transcriptional Regulation of Human Gonadotropin-Releasing Hormone I (GnRH I) Receptor, GnRH I, and GnRH II J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1106 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, B. K. C. Chow, and P. C. K. Leung An Activator Protein 1-Like Motif Mediates 17{beta}-Estradiol Repression of Gonadotropin-Releasing Hormone Receptor Promoter via an Estrogen Receptor {alpha}-Dependent Mechanism in Ovarian and Breast Cancer Cells Mol. Endocrinol., December 1, 2003; 17(12): 2613 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, C. M. Yeung, R. L. C. Hoo, B. K. C. Chow, and P. C. K. Leung Oct-1 Is Involved in the Transcriptional Repression of the Gonadotropin-Releasing Hormone Receptor Gene Endocrinology, December 1, 2002; 143(12): 4693 - 4701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, C. M. Yeung, B. K. C. Chow, and P. C. K. Leung Characterization of a New Upstream GnRH Receptor Promoter in Human Ovarian Granulosa-Luteal Cells Mol. Endocrinol., July 1, 2002; 16(7): 1552 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Garcia-Velasco, V. Isaza, C. Vidal, A. Landazabal, J. Remohi, C. Simon, and A. Pellicer Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix) Hum. Reprod., December 1, 2001; 16(12): 2533 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ortmann, J.M. Weiss, and K. Diedrich Embryo implantation and GnRH antagonists: Ovarian actions of GnRH antagonists Hum. Reprod., April 1, 2001; 16(4): 608 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chiang, K. W. Cheng, S. Igarashi, P. S. Nathwani, and P. C. K. Leung Hormonal Regulation of Estrogen Receptor {alpha} and {beta} Gene Expression in Human Granulosa-Luteal Cells in Vitro J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3828 - 3839. [Abstract] [Full Text] |
||||
![]() |
J. Dor, D. Bider, A. Shulman, J. Levron, S. Shine, S. Mashiach, and J. Rabinovici Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro--results of a prospective, randomized in-vitro fertilization study Hum. Reprod., June 1, 2000; 15(6): 1225 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.H. Mehta and T.C. Anand Kumar Can GnRH agonists act directly on the ovary and contribute to cyst formation? Hum. Reprod., March 1, 2000; 15(3): 505 - 507. [Full Text] [PDF] |
||||
![]() |
Y. Lin, J. A. Kahn, and T. Hillensjo Is there a difference in the function of granulosa–luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Hum. Reprod., April 1, 1999; 14(4): 885 - 888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |